For COL4A2, we found no significant associations with the patients' outcome, irrespective of sex.<h4>Conclusions</h4>p120-catenin is a potential tumor-promoting factor in glioma, and a prognostic marker in GBM. This evidence concerns the gene COL4A2 and glioblastoma.